Clik here to view.
“You Only Have to Be Right Once”
Before you dismiss this idea as a bubble, consider a sector far more lucrative than your fantasy sports league The post “You Only Have to Be Right Once” appeared first on Agora Financial.
View ArticleClik here to view.
Strategic Intelligence Portfolio Update
A complete portfolio update for the month of September The post Strategic Intelligence Portfolio Update appeared first on Agora Financial.
View ArticleClik here to view.
Two Spinoffs in Q4 & How to Find Insider Ownership
As we approach the final quarter of the year, there are a couple of spinoffs I’m looking forward to. The post Two Spinoffs in Q4 & How to Find Insider Ownership appeared first on Agora Financial.
View ArticleClik here to view.
BRIEFING: Jim Rickards Unplugged
In this month’s live intelligence briefing Jim issues an update on current events from the last 30 days and how they affect his investment thesis and offers an extended lightning round… The post...
View ArticleClik here to view.
Forget the Fed! These Stocks Are Jumping No Matter What…
Over the past three months, the iShares Dow Jones U.S. Home Construction ETF (NYSE:ITB) is up nearly 5%. Sure, the homebuilder ETF dipped during the market’s August selloff. But it’s shaken off this...
View ArticleClik here to view.
The Bear Market Starts…Here Come the Helicopters!… G-20 Promises About...
Here are the five articles I recommend you read this week. You’ll see the start of the bear market… Here come the helicopters!... G-20 promises about currency wars… and more! The post The Bear Market...
View ArticleClik here to view.
New IMPACT Buy: Schrodinger’s CAT
Our latest IMPACT analysis and a put option that could triple in value over the next six-12 months! The post New IMPACT Buy: Schrodinger’s CAT appeared first on Agora Financial.
View ArticleClik here to view.
Doing More of What’s Working: Collect Another $195 From This Winner
Today we’re collecting another $195 from our winning homebuilder position by following the advice of my mentor who showed me how to tap the markets for maximum amounts of income. The post Doing More of...
View ArticleClik here to view.
A 20-Year-Old Drug Company Wakes up Wall Street
Despite the economic downturn, and no marketable products (yet), this month’s recommendation has only been on the up and up. The post A 20-Year-Old Drug Company Wakes up Wall Street appeared first on...
View ArticleClik here to view.
The Monkey That Got Its Grip Back
The quest for a Parkinson’s breakthrough, and a rare opportunity for early investors to make 10 times their money. Plus: One asset class set to win no matter what the Fed does Thursday The post The...
View ArticleClik here to view.
You Can’t Afford to Ignore This Threat Any Longer…
Cybersecurity is shaping up to become the play of the decade. No information is as secure as it seems. And most corporations are painfully behind the curve when it comes to protecting their data-- and...
View ArticleClik here to view.
Midweek Briefing — The IEA’s $7.7 Billion Rounding Error
Today, I want to walk you through the giant hole in the IEA analysis that the agency doesn’t even try to hide. The post Midweek Briefing — The IEA’s $7.7 Billion Rounding Error appeared first on Agora...
View ArticleClik here to view.
Here’s Why There’s a Never-Ending Stream of Profits in Your Refrigerator
Head over to your refrigerator and open it up. Can you spot the investment opportunity in there? A tiny company you've probably never heard of holds the keys to the gains tucked inside your...
View ArticleClik here to view.
Bonus Trade Alert: Capture an Extra $350 Waiting for This Equipment Company...
Oil prices are stabilizing right now, which is great news for our oil equipment companies. So today, we’re going to collect an instant $350 from one of these companies as its outlook brightens The post...
View ArticleClik here to view.
Take 65% Profits on Our Retail Puts
We recommend you sell our retail puts for a 65% gain… The post Take 65% Profits on Our Retail Puts appeared first on Agora Financial.
View ArticleClik here to view.
Treatment vs. Cures
If treating a disease generates 1,100% gains… what about a cure? Plus: Door No. 2: Jim Rickards on why this week’s Fed meeting won’t stop the market volatility The post Treatment vs. Cures appeared...
View ArticleClik here to view.
This Portfolio Position Validated by New Agreement
This portfolio position just acquired something of a sweetheart deal. The post This Portfolio Position Validated by New Agreement appeared first on Agora Financial.
View ArticleClik here to view.
Staying Ahead of the Fed
The Federal Reserve's policy-setting committee is meeting today, kicking off a two-day discussion of what the central bank should do about interest rates. It's pretty much the only thing that the...
View ArticleClik here to view.
New BUY Alert: How a Consumer “Cult” Could Lead Us to Nice Gains
A company with a core group of loyal customers has been oversold – meaning we can buy it for a great price now and ride it higher as its customers continue to spend more. The post New BUY Alert: How a...
View ArticleClik here to view.
Staying Ahead of the Fed
The Federal Reserve's policy-setting committee is meeting today, kicking off a two-day discussion of what the central bank should do about interest rates. It's pretty much the only thing that the...
View Article